Cargando…

Chemoradiotherapy Alters Protein Expression in Glioblastoma Multiforme

Detalles Bibliográficos
Autores principales:	Hwang, Mina, Park, Hyun-Hee, Han, Myung-Hoon, Choi, Hojin, Lee, Kyu-Yong, Lee, Young Joo, Kim, Jae Min, Cheong, Jin Hwan, Ryu, Je Il, Ko, Yong, Koh, Seong-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541983/ https://www.ncbi.nlm.nih.gov/pubmed/33029989 http://dx.doi.org/10.3988/jcn.2020.16.4.725

Ejemplares similares

LGR5 and Downstream Intracellular Signaling Proteins Play Critical Roles in the Cell Proliferation of Neuroblastoma, Meningioma and Pituitary Adenoma
por: Hwang, Mina, et al.
Publicado: (2019)

Mitochondria damaged by Oxygen Glucose Deprivation can be Restored through Activation of the PI3K/Akt Pathway and Inhibition of Calcium Influx by Amlodipine Camsylate
por: Park, Hyun-Hee, et al.
Publicado: (2019)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

Leptomeningeal Spread at the Diagnosis of Glioblastoma Multiforme: A Case Report and Literature Review
por: Jang, Cheolwon, et al.
Publicado: (2022)

DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2023)

Exploratory Analysis of the Copy Number Alterations in Glioblastoma Multiforme
por: Freire, Pablo, et al.
Publicado: (2008)

Identification of genes from ten oncogenic pathways associated with mortality and disease progression in glioblastoma
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study
por: Mohammed, Soniya, et al.
Publicado: (2022)

The genes significantly associated with an improved prognosis and long-term survival of glioblastoma
por: Yoon, Hong Gyu, et al.
Publicado: (2023)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Altered Expression of Polycomb Group Genes in Glioblastoma Multiforme
por: Li, Gang, et al.
Publicado: (2013)

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
por: Park, Jang Hyun, et al.
Publicado: (2022)

High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Nogo receptor–vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme
por: Kang, Yun Hee, et al.
Publicado: (2019)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
por: Han, Myung-Hoon, et al.
Publicado: (2022)

The Osteoporotic Condition as a Predictive Factor for Hemorrhagic Transformation in Acute Cardioembolic Stroke
por: Won, Yu Deok, et al.
Publicado: (2021)

Effect of Possible Osteoporosis on Parenchymal-Type Hemorrhagic Transformation in Patients with Cardioembolic Stroke
por: Won, Yu-Deok, et al.
Publicado: (2021)

Specificity Protein 1 Expression Contributes to Bcl-w-Induced Aggressiveness in Glioblastoma Multiforme
por: Lee, Woo Sang, et al.
Publicado: (2014)

Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas
por: Shin, Chansub, et al.
Publicado: (2021)

Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
por: Lim, Xin Yuan, et al.
Publicado: (2023)

Expression of PGC1α in glioblastoma multiforme patients
por: Cho, Sang Yeon, et al.
Publicado: (2017)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Candesartan Restores the Amyloid Beta-Inhibited Proliferation of Neural Stem Cells by Activating the Phosphatidylinositol 3-Kinase Pathway
por: Choi, Hojin, et al.
Publicado: (2017)

Evaluation of early imaging response criteria in glioblastoma multiforme
por: Gladwish, Adam, et al.
Publicado: (2011)

Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3vl0qc8g31p9gknvc21om453f1